Deep learning techniques for fatty liver using multi-view ultrasound images scanned by different scanners:development and validation study

Background: Fat fraction values obtained from magnetic resonance imaging (MRI) can be used to obtain an accurate diagnosis of fatty liver diseases. However, MRI is expensive and cannot be performed for everyone. Objective: In this study, we aim to develop multi-view ultrasound image-based convolutional deep learning models to detect fatty liver disease and yield fat fraction values. Methods: We extracted 90 ultrasound images of the right intercostal view and 90 ultrasound images of the right intercostal view containing the right renal cortex from 39 cases of fatty liver (MRI-proton density fat fraction [MRI-PDFF] ≥ 5%) and 51 normal subjects (MRI-PDFF < 5%), with MRI-PDFF values obtained from Good Gang-An Hospital. We obtained combined liver and kidney-liver (CLKL) images to train the deep learning models and developed classification and regression models based on the VGG19 model to classify fatty liver disease and yield fat fraction values. We employed the data augmentation techniques such as flip and rotation to prevent the deep learning model from overfitting. We determined the deep learning model with performance metrics such as accuracy, sensitivity, specificity, and coefficient of determination (R2). Results: In demographic information, all metrics such as age and sex were similar between the two groups-fatty liver disease and normal subjects. In classification, the model trained on CLKL images achieved 80.1% accuracy, 86.2% precision, and 80.5% specificity to detect fatty liver disease. In regression, the predicted fat fraction values of the regression model trained on CLKL images correlated with MRI-PDFF values (R2=0.633), indicating that the predicted fat fraction values were moderately estimated. Conclusions: With deep learning techniques and multi-view ultrasound images, it is potentially possible to replace MRI-PDFF values with deep learning predictions for detecting fatty liver disease and estimating fat fraction values.